Journals / Cardiovascular surgery and interventions / 2022 / Cilt: 9 - Sayı: 1

Prior left ventricular systolic dysfunction is an independent predictor of in-hospital mortality in patients with COVID-19

Pages
1–8
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A left ventricular ejection fraction (LVEF%) of

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to examine the effect of left ventricular systolic dysfunction (LVSD) on in-hospital mortality in patients hospitalized for novel coronavirus disease 2019 (COVID-19).
📊
Key Findings & Data:Patients and methods: Between June 2020 and December 2020, a total of 847 patients (423 males, 424 females; median age: 68 years; range, 58 to 77 years) who had echocardiography and had positive real-time reverse transcriptase-polymerase chain reaction were retrospectively analyzed.
💡
Conclusion & Impact:A left ventricular ejection fraction (LVEF%) of
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to examine the effect of left ventricular systolic dysfunction (LVSD) on in-hospital mortality in patients hospitalized for novel coronavirus disease 2019 (COVID-19). Patients and methods: Between June 2020 and December 2020, a total of 847 patients (423 males, 424 females; median age: 68 years; range, 58 to 77 years) who had echocardiography and had positive real-time reverse transcriptase-polymerase chain reaction were retrospectively analyzed. A left ventricular ejection fraction (LVEF%) of

🔖

Cite This Article

Bilge, Ö., Işık, F., Akyüz, A., İnci, Ü., Çap, M., Kaya, İ., Karagöz, A., Tatlı, İ. (2022). Prior left ventricular systolic dysfunction is an independent predictor of in-hospital mortality in patients with COVID-19. Cardiovascular surgery and interventions, Cilt: 9 - Sayı: 1, 1–8. https://ajindex.com/articles/470966

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. World Health Organization. (2020) Naming the coronavirus disease(COVID-19 and the virus that causes it. World Health Organization. Available at: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019/technical- guidance/naming-the-coronavirus-disease-(covid-2019)- and-the-virus-that-causes-it [Accessed: February 01, 2020] 2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020
  2. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with different severities: A multicenter study of clinical features. Am J Respir Crit Care Med 2020
  3. Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res 2020
  4. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020
  5. Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, et al. Spectrum of cardiac manifestations in COVID- 19: A systematic echocardiographic study. Circulation 2020
  6. Panhwar MS, Kalra A, Gupta T, Kolte D, Khera S, Bhatt DL, et al. Effect of influenza on outcomes in patients with heart failure. JACC Heart Fail 2019
  7. Jobs A, Simon R, de Waha S, Rogacev K, Katalinic A, Babaev V, et al. Pneumonia and inflammation in acute decompensated heart failure: A registry-based analysis of 1939 patients. Eur Heart J Acute Cardiovasc Care 2018
  8. Rey JR, Caro-Codón J, Rosillo SO, Iniesta ÁM, Castrejón- Castrejón S, Marco-Clement I, et al. Heart failure in COVID-19 patients: Prevalence, incidence and prognostic implications. Eur J Heart Fail 2020
  9. Kim M, Nam JH, Son JW, Kim SO, Son NH, Ahn CM, et al. Cardiac manifestations of coronavirus disease 2019 (COVID-19): A multicenter cohort study. J Korean Med Sci 2020
  10. e366. 11. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015
  11. e14. 12. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contributi